IVERIC bio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IVERIC bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q1 2023.
  • IVERIC bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$73.8M, a 113% decline year-over-year.
  • IVERIC bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$229M, a 86.9% decline year-over-year.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2022 was -$190M, a 65.5% decline from 2021.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2021 was -$115M, a 29.3% decline from 2020.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2020 was -$88.7M, a 44.8% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$229M -$73.8M -$39.2M -113% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$190M -$63M -$29.9M -90.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 -$160M -$42.5M -$17.9M -72.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 -$142M -$49.8M -$19.5M -64.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-26
Q1 2022 -$123M -$34.7M -$7.8M -29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$115M -$33.1M -$7.6M -29.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$107M -$24.6M +$901K +3.54% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$108M -$30.2M -$11.2M -58.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-26
Q1 2021 -$96.9M -$26.9M -$8.12M -43.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$88.7M -$25.5M -$7.65M -42.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 -$81.1M -$25.5M -$10.4M -69.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$70.7M -$19M -$3.8M -25% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$66.9M -$18.7M -$5.58M -42.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$61.3M -$17.8M +$3.95M +18.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$65.2M -$15.1M +$318K +2.07% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 -$65.5M -$15.2M -$359K -2.42% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 -$65.2M -$13.2M +$165K +1.24% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
Q4 2018 -$65.3M -$21.8M -$6.94M -46.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$58.4M -$15.4M -$204M -108% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $146M -$14.8M +$7.7M +34.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $138M -$13.3M +$30.1M +69.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $108M -$14.9M +$52.2M +77.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $55.8M $189M +$250M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$194M -$22.5M +$8.01M +26.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$202M -$43.5M -$6.73M -18.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$196M -$67.1M -$25.9M -62.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 -$170M -$61.2M -$13.8M -29% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-05
Q2 2016 -$156M -$30.6M +$11.9M +28% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-05
Q1 2016 -$168M -$36.7M -$44.3M -588% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-05
Q4 2015 -$124M -$41.2M -$10M -32.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$113M -$47.4M -$61.1M -447% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 -$52.4M -$42.4M -$144K -0.34% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 -$52.3M $7.54M +$28.3M Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$80.5M -$31.2M -$10.7M -52.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 -$69.8M $13.7M +$28.9M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$98.7M -$42.3M -$34.7M -457% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 -$64M -$20.7M -$16.6M -402% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 -$47.4M -$20.4M -$16.9M -477% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-07-28
Q3 2013 -$30.5M -$15.3M -$11.4M -296% Jul 1, 2013 Sep 30, 2013 10-K/A 2015-07-28
Q2 2013 -$19.1M -$7.59M -$4.31M -132% Apr 1, 2013 Jun 30, 2013 10-K/A 2015-07-28
Q1 2013 -$14.8M -$4.13M -$1.12M -37.2% Jan 1, 2013 Mar 31, 2013 10-K/A 2015-07-28
Q4 2012 -$13.7M -$3.55M Oct 1, 2012 Dec 30, 2012 10-K 2014-03-11
Q3 2012 -$3.85M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 -$3.27M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-11
Q1 2012 -$3.01M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.